Global Human Organoids Market Research Report 2021

1 Human Organoids Market Overview

• 1.1 Product Overview and Scope of Human Organoids
• 1.2 Human Organoids Segment by Type
  • 1.2.1 Global Human Organoids Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Ready To Use Products
  • 1.2.3 Customizable Products
• 1.3 Human Organoids Segment by Application
  • 1.3.1 Human Organoids Sales Comparison by Application: (2021-2027)
  • 1.3.2 Developmental Biology
  • 1.3.3 Drug Toxicity & Efficacy Testing
  • 1.3.4 Disease Pathology
  • 1.3.5 Personalized Medicine
  • 1.3.6 Regenerative Medicine
  • 1.3.7 Other
• 1.4 Global Human Organoids Market Size Estimates and Forecasts
  • 1.4.1 Global Human Organoids Revenue 2016-2027
  • 1.4.2 Global Human Organoids Sales 2016-2027
  • 1.4.3 Human Organoids Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human Organoids Market Competition by Manufacturers

• 2.1 Global Human Organoids Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Human Organoids Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Human Organoids Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Human Organoids Manufacturing Sites, Area Served, Product Type
• 2.5 Human Organoids Market Competitive Situation and Trends
  • 2.5.1 Human Organoids Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Human Organoids Players Market Share by Revenue
  • 2.5.3 Global Human Organoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Organoids Retrospective Market Scenario by Region

• 3.1 Global Human Organoids Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Human Organoids Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Human Organoids Market Facts & Figures by Country
  • 3.3.1 North America Human Organoids Sales by Country
  • 3.3.2 North America Human Organoids Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Human Organoids Market Facts & Figures by Country
  • 3.4.1 Europe Human Organoids Sales by Country
  • 3.4.2 Europe Human Organoids Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Human Organoids Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Human Organoids Sales by Region
  • 3.5.2 Asia Pacific Human Organoids Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Human Organoids Market Facts & Figures by Country
  • 3.6.1 Latin America Human Organoids Sales by Country
  • 3.6.2 Latin America Human Organoids Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Human Organoids Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Human Organoids Sales by Country
  • 3.7.2 Middle East and Africa Human Organoids Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Human Organoids Historic Market Analysis by Type

• 4.1 Global Human Organoids Sales Market Share by Type (2016-2021)
• 4.2 Global Human Organoids Revenue Market Share by Type (2016-2021)
• 4.3 Global Human Organoids Price by Type (2016-2021)

5 Global Human Organoids Historic Market Analysis by Application

• 5.1 Global Human Organoids Sales Market Share by Application (2016-2021)
• 5.2 Global Human Organoids Revenue Market Share by Application (2016-2021)
• 5.3 Global Human Organoids Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 BioIVT (US)
  • 6.1.1 BioIVT (US) Corporation Information
  • 6.1.2 BioIVT (US) Description and Business Overview
  • 6.1.3 BioIVT (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 BioIVT (US) Product Portfolio
  • 6.1.5 BioIVT (US) Recent Developments/Updates
• 6.2 Thermo Fisher Scientific (US)
  • 6.2.1 Thermo Fisher Scientific (US) Corporation Information
  • 6.2.2 Thermo Fisher Scientific (US) Description and Business Overview
  • 6.2.3 Thermo Fisher Scientific (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Thermo Fisher Scientific (US) Product Portfolio
  • 6.2.5 Thermo Fisher Scientific (US) Recent Developments/Updates
• 6.3 ZenBio (US)
  • 6.3.1 ZenBio (US) Corporation Information
  • 6.3.2 ZenBio (US) Description and Business Overview
  • 6.3.3 ZenBio (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 ZenBio (US) Product Portfolio
  • 6.3.5 ZenBio (US) Recent Developments/Updates
• 6.4 Corning (US)
  • 6.4.1 Corning (US) Corporation Information
  • 6.4.2 Corning (US) Description and Business Overview
  • 6.4.3 Corning (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Corning (US) Product Portfolio
  • 6.4.5 Corning (US) Recent Developments/Updates
• 6.5 Organovo (US)
  • 6.5.1 Organovo (US) Corporation Information
  • 6.5.2 Organovo (US) Description and Business Overview
  • 6.5.3 Organovo (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Organovo (US) Product Portfolio
  • 6.5.5 Organovo (US) Recent Developments/Updates
• 6.6 Cyprio (France)
  • 6.6.1 Cyprio (France) Corporation Information
  • 6.6.2 Cyprio (France) Description and Business Overview
  • 6.6.3 Cyprio (France) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Cyprio (France) Product Portfolio
  • 6.6.5 Cyprio (France) Recent Developments/Updates
• 6.7 Biopredic International (France)
  • 6.6.1 Biopredic International (France) Corporation Information
  • 6.6.2 Biopredic International (France) Description and Business Overview
  • 6.6.3 Biopredic International (France) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biopredic International (France) Product Portfolio
  • 6.7.5 Biopredic International (France) Recent Developments/Updates
• 6.8 CELLINK (Sweden)
  • 6.8.1 CELLINK (Sweden) Corporation Information
  • 6.8.2 CELLINK (Sweden) Description and Business Overview
  • 6.8.3 CELLINK (Sweden) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 CELLINK (Sweden) Product Portfolio
  • 6.8.5 CELLINK (Sweden) Recent Developments/Updates
• 6.9 Emulate (US)
  • 6.9.1 Emulate (US) Corporation Information
  • 6.9.2 Emulate (US) Description and Business Overview
  • 6.9.3 Emulate (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Emulate (US) Product Portfolio
  • 6.9.5 Emulate (US) Recent Developments/Updates
• 6.10 Hrel Corporation (US)
  • 6.10.1 Hrel Corporation (US) Corporation Information
  • 6.10.2 Hrel Corporation (US) Description and Business Overview
  • 6.10.3 Hrel Corporation (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Hrel Corporation (US) Product Portfolio
  • 6.10.5 Hrel Corporation (US) Recent Developments/Updates
• 6.11 InSphero (Switzerland)
  • 6.11.1 InSphero (Switzerland) Corporation Information
  • 6.11.2 InSphero (Switzerland) Human Organoids Description and Business Overview
  • 6.11.3 InSphero (Switzerland) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 InSphero (Switzerland) Product Portfolio
  • 6.11.5 InSphero (Switzerland) Recent Developments/Updates
• 6.12 Kerafast (US)
  • 6.12.1 Kerafast (US) Corporation Information
  • 6.12.2 Kerafast (US) Human Organoids Description and Business Overview
  • 6.12.3 Kerafast (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Kerafast (US) Product Portfolio
  • 6.12.5 Kerafast (US) Recent Developments/Updates
• 6.13 Kirkstall (UK)
  • 6.13.1 Kirkstall (UK) Corporation Information
  • 6.13.2 Kirkstall (UK) Human Organoids Description and Business Overview
  • 6.13.3 Kirkstall (UK) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Kirkstall (UK) Product Portfolio
  • 6.13.5 Kirkstall (UK) Recent Developments/Updates
• 6.14 MIMETAS (Netherlands)
  • 6.14.1 MIMETAS (Netherlands) Corporation Information
  • 6.14.2 MIMETAS (Netherlands) Human Organoids Description and Business Overview
  • 6.14.3 MIMETAS (Netherlands) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 MIMETAS (Netherlands) Product Portfolio
  • 6.14.5 MIMETAS (Netherlands) Recent Developments/Updates
• 6.15 Pandorum Technologies (India)
  • 6.15.1 Pandorum Technologies (India) Corporation Information
  • 6.15.2 Pandorum Technologies (India) Human Organoids Description and Business Overview
  • 6.15.3 Pandorum Technologies (India) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Pandorum Technologies (India) Product Portfolio
  • 6.15.5 Pandorum Technologies (India) Recent Developments/Updates
• 6.16 Promethera Biosciences (Belgium)
  • 6.16.1 Promethera Biosciences (Belgium) Corporation Information
  • 6.16.2 Promethera Biosciences (Belgium) Human Organoids Description and Business Overview
  • 6.16.3 Promethera Biosciences (Belgium) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Promethera Biosciences (Belgium) Product Portfolio
  • 6.16.5 Promethera Biosciences (Belgium) Recent Developments/Updates
• 6.17 Miromatrix (US)
  • 6.17.1 Miromatrix (US) Corporation Information
  • 6.17.2 Miromatrix (US) Human Organoids Description and Business Overview
  • 6.17.3 Miromatrix (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Miromatrix (US) Product Portfolio
  • 6.17.5 Miromatrix (US) Recent Developments/Updates
• 6.18 System1 Biosciences (US)
  • 6.18.1 System1 Biosciences (US) Corporation Information
  • 6.18.2 System1 Biosciences (US) Human Organoids Description and Business Overview
  • 6.18.3 System1 Biosciences (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 System1 Biosciences (US) Product Portfolio
  • 6.18.5 System1 Biosciences (US) Recent Developments/Updates
• 6.19 Cyfuse Biomedical (Japan)
  • 6.19.1 Cyfuse Biomedical (Japan) Corporation Information
  • 6.19.2 Cyfuse Biomedical (Japan) Human Organoids Description and Business Overview
  • 6.19.3 Cyfuse Biomedical (Japan) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Cyfuse Biomedical (Japan) Product Portfolio
  • 6.19.5 Cyfuse Biomedical (Japan) Recent Developments/Updates

7 Human Organoids Manufacturing Cost Analysis

• 7.1 Human Organoids Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Human Organoids
• 7.4 Human Organoids Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Human Organoids Distributors List
• 8.3 Human Organoids Customers

9 Human Organoids Market Dynamics

• 9.1 Human Organoids Industry Trends
• 9.2 Human Organoids Growth Drivers
• 9.3 Human Organoids Market Challenges
• 9.4 Human Organoids Market Restraints

10 Global Market Forecast

• 10.1 Human Organoids Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Human Organoids by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Human Organoids by Type (2022-2027)
• 10.2 Human Organoids Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Human Organoids by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Human Organoids by Application (2022-2027)
• 10.3 Human Organoids Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Human Organoids by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Human Organoids by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List